Brief: Sensei Biotherapeutics Reports 2022 Of $1.58
March 28 (Reuters) - Sensei Biotherapeutics Inc
SNSE.O :
* SENSEI BIOTHERAPEUTICS REPORTS FULL YEAR 2022 FINANCIAL
RESULTS
AND RECENT BUSINESS HIGHLIGHTS
* STRONG BALANCE SHEET WITH CASH RUNWAY INTO SECOND HALF OF
2025
* FY LOSS PER SHARE $1.58
* FY2022 EARNINGS PER SHARE VIEW $-1.59 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNX1w9Yyz
Further company coverage: SNSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Faeth Therapeutics,
See all newsBrief: Sensei Biotherapeutics Announces Name Change To Faeth Therapeutics
Brief: Sensei Biotherapeutics Doses First Patient In Phase 1B/2 Trial Of Piktor In Hr+/Her2- Advanced Breast Cancer
Brief: Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)